Summary

Persistence Market Research has recently released a comprehensive report on the US market for Assisted Reproductive Technology (ART). This report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• US ART Market Size (2024E): US$3.6 Bn
• Projected Market Value (2031F): US$11.3 Bn
• US Market Growth Rate (CAGR 2024 to 2031): 17.8%

US ART Market - Report Scope:

Assisted Reproductive Technology (ART) encompasses a range of medical procedures used to address infertility and assist individuals in achieving pregnancy. These technologies include in vitro fertilization (IVF), intrauterine insemination (IUI), egg donation, sperm donation, and embryo freezing. The ART market caters to fertility clinics, hospitals, and research institutions, offering advanced reproductive solutions to individuals and couples facing fertility challenges. Market growth is driven by increasing infertility rates, rising awareness about ART, advancements in reproductive technologies, and supportive healthcare policies.

Market Growth Drivers:

The US ART market is propelled by several key factors, including a rising incidence of infertility due to lifestyle factors and delayed childbearing. Increasing awareness about ART options and growing acceptance of assisted reproduction among diverse demographic groups further drive market expansion. Technological advancements, such as the development of new fertility drugs, improved IVF techniques, and enhanced embryo screening methods, contribute to higher success rates and improved patient outcomes. Additionally, the expansion of insurance coverage for ART procedures and the growing availability of fertility preservation options create new growth opportunities in the market.

Market Restraints:

Despite promising growth prospects, the ART market faces challenges related to high treatment costs, regulatory complexities, and ethical concerns. The high cost of ART procedures, including IVF cycles and associated medications, can be a barrier for many patients, particularly those without comprehensive insurance coverage. Regulatory hurdles and varying state policies regarding ART practices can impact market accessibility and operational efficiency. Ethical concerns related to embryo manipulation and genetic screening also pose challenges, necessitating ongoing dialogue and policy development to address these issues.

Market Opportunities:

The ART market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare policies. Advances in genetic screening, such as preimplantation genetic testing (PGT), offer improved success rates and reduced risks of genetic disorders. The increasing focus on personalized medicine and patient-centric care enhances the development of tailored ART solutions. Furthermore, the growing trend of fertility preservation among individuals delaying parenthood and the rising popularity of fertility tourism provide additional avenues for market expansion. Strategic partnerships, investment in research and development, and the introduction of cost-effective ART solutions are essential to capitalize on these emerging opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the US ART market?
• Which ART procedures and technologies are driving adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the ART market?
• Who are the key players contributing to the US ART market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the US ART market?

Competitive Intelligence and Business Strategy:

Leading players in the US ART market, including IVF America, CooperSurgical, and Merck KGaA, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced ART technologies, including next-generation IVF platforms, enhanced fertility drugs, and improved embryo culture systems. Collaborations with healthcare providers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving ART landscape.

Key Companies Profiled:

• IVF America
• CooperSurgical
• Merck KGaA
• Ferring Pharmaceuticals
• OvaScience, Inc.
• Hamilton Thorne Ltd.
• Genomics Medicine Ireland
• EMD Serono, Inc.
• Reproductive Medicine Associates of New Jersey
• The Jones Institute

US Assisted Reproductive Technology Market Segmentation

By Technique
• IVF
• Artificial Insemination

By Procedure
• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

By End Use
• Fertility Clinics
• Hospitals

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. U.S. Assisted Reproductive Technology Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. U.S. GDP Growth Outlook
2.3.2. U.S. Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Service Adoption Analysis
3.2. Regulatory Landscape
3.3. Key Deals and Mergers
3.4. List of Service Providers
3.5. Technology Assessment
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. U.S. Assisted Reproductive Technology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023–2031
4.3. U.S. Assisted Reproductive Technology Market Outlook: Technique
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Technique, 2019-2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technique, 2023 – 2031
4.3.3.1. IVF
4.3.3.2. Artificial Insemination
4.4. Market Attractiveness Analysis: Technique
4.5. U.S. Assisted Reproductive Technology Market Outlook: Procedure
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Procedure, 2019-2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Procedure, 2023 – 2031
4.5.3.1. Fresh Donor
4.5.3.2. Fresh Non-Donor
4.5.3.3. Frozen Donor
4.5.3.4. Frozen Non-Donor
4.6. Market Attractiveness Analysis: Procedure
4.7. U.S. Assisted Reproductive Technology Market Outlook: End User
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 – 2031
4.7.3.1. Fertility Clinics
4.7.3.2. Hospitals
4.8. Market Attractiveness Analysis: End User
5. Competition Landscape
5.1. Market Share Analysis, 2023
5.2. Market Structure
5.2.1. Competition Intensity Mapping By Market
5.2.2. Competition Dashboard
5.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
5.3.1. The Fertility Institutes
5.3.1.1. Overview
5.3.1.2. Segments and Products
5.3.1.3. Key Financials
5.3.1.4. Market Developments
5.3.1.5. Market Strategy
5.3.2. Shady Grove Fertility
5.3.3. Pacific Fertility Centre
5.3.4. Boston IVF
5.3.5. Cleveland Clinic Fertility Centre
5.3.6. Reproductive Medicine Associates of New Jersey (RMANJ)
5.3.7. Columbia University Fertility Centre
5.3.8. Mayo Clinic Fertility Centre
5.3.9. Texas Fertility Centre
5.3.10. UCSF Centre for Reproductive Health
6. Appendix
6.1. Research Methodology
6.2. Research Assumptions
6.3. Acronyms and Abbreviations